Doncaster Pharmaceuticals Group Ltd.& Ors v The Bolton Pharmaceutical Company 100 Ltd

Summary judgment is appropriate only where the opposing case has no real prospect of success and no other compelling reason requires a trial. A real prospect is more than fanciful or merely arguable. The court must avoid resolving material factual conflicts or conducting a mini-trial.

In a trade mark parallel-import case, a territorial assignment does not by itself end the summary-judgment inquiry. A trial may be required where fuller evidence could establish continuing economic links, a possibility of quality control, or deliberate artificial partitioning of the EU market. Those matters may determine whether the proprietor’s rights are exhausted and whether enforcement constitutes a disguised restriction on trade.

Doncaster Pharmaceuticals Group Ltd. & Ors v The Bolton Pharmaceutical Company 100 Ltd [2006] EWCA Civ 661 concerned two similar trade mark infringement actions against importers of KALTEN pharmaceutical capsules from Spain. The importers repackaged and relabelled the capsules for sale in the United Kingdom.

The deputy High Court judge granted final summary judgments to the proprietor of the UK mark on 15 July 2005. He considered that neither exhaustion of rights nor estoppel had a real prospect of success. The defendants appealed.

The central issue was whether liability and remedies could properly be determined under Part 24 without disclosure, cross-examination and fuller investigation of the successive territorial assignments, related commercial agreements, possible economic links and possible continuing control by the original proprietor.

1. Appeals allowed unanimously. The summary judgments could not stand. The infringement claims, including liability and remedies, required trial after fuller disclosure and evidence. Permission to adduce the further evidence tendered on appeal was granted.
2. Under Part 24.2 of the Civil Procedure Rules, summary judgment is available only where the opposing case has no real prospect of success and no other compelling reason requires a trial. A real prospect must be more than fanciful or merely arguable. The court must avoid a mini-trial. It should hesitate where reasonable grounds exist for believing that fuller investigation would add to or alter the evidence and affect the outcome.
3. The essential function of a trade mark is to guarantee the origin of the goods. Under articles 28 and 30 of the EC Treaty, enforcement may be justified to protect that function. The exhaustion doctrine may nevertheless apply where goods were placed on the EU market by the proprietor, with its consent, or through a person connected by economic links or a possibility of control. The possibility of quality control, rather than its actual exercise, is material.
4. IHT Internationale Heiztechnik GmbH v Ideal-Standard GmbH [1994] ECR 1-2789 did not justify summary disposal. Although an assignment to an economically independent undertaking may surrender control and may not itself imply the consent required for exhaustion, that decision did not necessarily identify every circumstance in which exhaustion could arise. The successive assignments and related transactions had to be considered together. They might reveal deliberate artificial partitioning of the EU market, continuing economic links or a retained possibility of control. The assignments here were accompanied by product and technical-information arrangements which kept the original proprietor involved. The incomplete and redacted evidence therefore required investigation at trial.
5. The estoppel defence appeared doubtful, but the court would not declare it unarguable while the action was proceeding to trial on the exhaustion defence. The relabelling and repackaging notification issue was also left for trial. Any reference under article 234 of the EC Treaty could be considered after the relevant facts had been established.
6. Whether an action should proceed to trial is principally a matter of procedural law. Mummery LJ observed that there was no objection to specialist intellectual-property summary-judgment applications being heard by suitably experienced non-specialist judges.

1. Court of Appeal (Civil Division) — In Doncaster Pharmaceuticals Group Ltd. & Ors v The Bolton Pharmaceutical Company 100 Ltd [2006] EWCA Civ 661, the court unanimously allowed the appeals. It held that the actions were unsuitable for summary judgment and required trial after fuller factual investigation.
2. High Court, Chancery Division (Intellectual Property) — On 15 July 2005, Mr Terence Mowschenson QC, sitting as a deputy judge, granted the claimant final summary judgments under Part 24, including an inquiry as to damages. He held that the exhaustion and estoppel defences had no real prospect of success.